120 283

Cited 0 times in

Treatment outcome of patients with anaplastic thyroid cancer: a single center experience

 Sun Min Lim  ;  Sang-Joon Shin  ;  Woong Youn Chung  ;  Cheong Soo Park  ;  Kee-Hyun Nam  ;  Sang-Wook Kang  ;  Ki Chang Keum  ;  Joo Hang Kim  ;  Jae Yong Cho  ;  Yun Kyoung Hong  ;  Byoung Chul Cho 
 YONSEI MEDICAL JOURNAL, Vol.53(2) : 352-357, 2012 
Journal Title
Issue Date
Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Combined Modality Therapy ; Disease-Free Survival ; Doxorubicin/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Thyroid Carcinoma, Anaplastic ; Thyroid Neoplasms/drug therapy* ; Thyroid Neoplasms/mortality ; Treatment Outcome
Anaplastic thyroid cancer ; treatment outcome ; prognosis ; survival ; chemoradiotherapy
PURPOSE: Anaplastic thyroid cancer is known to have a poor prognosis due to its aggressive and rapid metastasis with median survival of less than 6 months. Multimodal treatment involving surgery and chemoradiotherapy has been used to improve the survival of patients. Here, we retrospectively review of treatment outcome of 13 consecutive patients who were treated at a single center. MATERIALS AND METHODS: We retrospectively reviewed medical records of 13 anaplastic thyroid cancer patients who received multidisciplinary treatment between 2006 and 2010. Kaplan-Meier survival curve was used to analyze progression-free survival and overall survival of patients. RESULTS: The median patient age at diagnosis was 69 years, and six patients had stage IVc diseases. Eight patients received primary surgery followed by radiotherapy or concurrent chemoradiotherapy (CCRT). Five patients received weekly doxorubicin-based definitive CCRT, but only one patient's condition remained stable, while the rest experienced rapid disease progression. The median progression-free survival was 2.8 months (95% CI, 1.2-4.4 months), and the median overall survival was 3.8 months (95% CI, 3.0-4.6 months). CONCLUSION: Patients with anaplastic thyroid cancer showed poor prognosis despite multimodality treatment. Therefore, identification of novel therapeutic targets is warranted to take an effective mode of treatment.
Files in This Item:
T201203218.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
Yonsei Authors
Kang, Sang Wook(강상욱) ORCID logo https://orcid.org/0000-0001-5355-833X
Keum, Ki Chang(금기창) ORCID logo https://orcid.org/0000-0003-4123-7998
Kim, Joo Hang(김주항)
Nam, Kee Hyun(남기현) ORCID logo https://orcid.org/0000-0002-6852-1190
Park, Cheong Soo(박정수)
Shin, Sang Joon(신상준) ORCID logo https://orcid.org/0000-0001-5350-7241
Lim, Sun Min(임선민)
Chung, Woung Youn(정웅윤)
Cho, Byoung Chul(조병철) ORCID logo https://orcid.org/0000-0002-5562-270X
Cho, Jae Yong(조재용) ORCID logo https://orcid.org/0000-0002-0926-1819
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.